Pilot project brings malaria preventive therapy closer to rural communities in Nigeria

1 April 2019

Each year, more than 50 million pregnant women in Africa are at risk of malaria. Without treatment, malaria in pregnancy can lead to maternal death, anemia and low birth weight – a major cause of infant mortality. Intermittent preventive treatment in pregnancy (IPTp) with the quality-assured medicine sulfadoxine-pyrimethamine (SP) can prevent the development of adverse malaria consequences.

1 / 10